Results 251 to 260 of about 32,113 (291)
Some of the next articles are maybe not open access.
Advanced Healthcare Materials, 2023
Inducing cell migration from the edges to the center of a wound, promoting angiogenesis, and controlling bacterial infection are very important for diabetic wound healing.
Haijun Shen +7 more
semanticscholar +1 more source
Inducing cell migration from the edges to the center of a wound, promoting angiogenesis, and controlling bacterial infection are very important for diabetic wound healing.
Haijun Shen +7 more
semanticscholar +1 more source
Advances in Hypoxia-Inducible Factor-1α Stabilizer Deferoxamine in Tissue Engineering
Tissue engineering. Part B, Reviews, 2022Deferoxamine (DFO) is an iron chelator with FDA approval for the clinical treatment of iron excess. As a well-established stabilizer of hypoxia-inducible factor-1α (HIF-1α), DFO can efficiently upregulate HIF-1α and relevant downstream angiogenic factors,
Yanlin Zhu +4 more
semanticscholar +1 more source
Seminars in Hematology, 2001
Despite the clinical use of deferoxamine for more than a quarter of a century, pharmacokinetic studies are few and have not been performed explicitly in patients with sickle cell disorders. Early studies with Intravenous administration to healthy volunteers and patients with transfusional overload showed that although peak concentrations of ...
openaire +2 more sources
Despite the clinical use of deferoxamine for more than a quarter of a century, pharmacokinetic studies are few and have not been performed explicitly in patients with sickle cell disorders. Early studies with Intravenous administration to healthy volunteers and patients with transfusional overload showed that although peak concentrations of ...
openaire +2 more sources
Plastic and Reconstructive Surgery, 2019
BACKGROUND The authors hypothesize that ischemic preconditioning of the recipient site with deferoxamine will increase fat graft survival by enhancing angiogenesis in a rat model.
Junhyung Kim +7 more
semanticscholar +1 more source
BACKGROUND The authors hypothesize that ischemic preconditioning of the recipient site with deferoxamine will increase fat graft survival by enhancing angiogenesis in a rat model.
Junhyung Kim +7 more
semanticscholar +1 more source
International Journal of Biological Macromolecules, 2022
Shengbo Li +12 more
semanticscholar +1 more source
Shengbo Li +12 more
semanticscholar +1 more source
Journal of Wound Care, 2018
OBJECTIVE Angiogenesis, formation of new vessels from pre-existing vessels, is an essential part of wound healing. We aimed to compare amniotic membrane extract with deferoxamine in angiogenesis and to assess any synergistic effect.
R. Farzan +6 more
semanticscholar +1 more source
OBJECTIVE Angiogenesis, formation of new vessels from pre-existing vessels, is an essential part of wound healing. We aimed to compare amniotic membrane extract with deferoxamine in angiogenesis and to assess any synergistic effect.
R. Farzan +6 more
semanticscholar +1 more source

